Originally developed to manage type 2 diabetes, these medications mimic the GLP-1 hormone, which plays a key role in regulating appetite, slowing gastric emptying, and enhancing feelings of fullness
If you experience syncope or near-syncope, avoid driving or operating machinery until evaluated by your healthcare provider
The decision to continue or discontinue GLP-1 therapy should be made collaboratively between the patient and their healthcare team, weighing the metabolic benefits against the risk of recurrent biliary symptoms
Both are compounded from licensed 503A pharmacies, both are HSA/FSA eligible, and both work toward the same weight loss goal
Retatrutide: The Triple Agonist The newest GLP-1 medication in development, retatrutide , is showing jaw-dropping results in clinical trials